A citation-based method for searching scientific literature

Julieta Afonso, Lúcio L Santos, Adhemar Longatto-Filho, Fátima Baltazar. Nat Rev Urol 2020
Times Cited: 24







List of co-cited articles
89 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
20

Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Matthew G Vander Heiden, Lewis C Cantley, Craig B Thompson. Science 2009
16

On the origin of cancer cells.
O WARBURG. Science 1956
12

Metabolic phenotype of bladder cancer.
Francesco Massari, Chiara Ciccarese, Matteo Santoni, Roberto Iacovelli, Roberta Mazzucchelli, Francesco Piva, Marina Scarpelli, Rossana Berardi, Giampaolo Tortora, Antonio Lopez-Beltran,[...]. Cancer Treat Rev 2016
88
12

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani,[...]. Cell 2017
798
12

Glycosylation in health and disease.
Colin Reily, Tyler J Stewart, Matthew B Renfrow, Jan Novak. Nat Rev Nephrol 2019
278
8

Metabolic regulation of cell growth and proliferation.
Jiajun Zhu, Craig B Thompson. Nat Rev Mol Cell Biol 2019
155
8

Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.
Madhusudhanan Sukumar, Jie Liu, Yun Ji, Murugan Subramanian, Joseph G Crompton, Zhiya Yu, Rahul Roychoudhuri, Douglas C Palmer, Pawel Muranski, Edward D Karoly,[...]. J Clin Invest 2013
448
8


The Mitochondrion as an Emerging Therapeutic Target in Cancer.
Katherine G Roth, Isa Mambetsariev, Prakash Kulkarni, Ravi Salgia. Trends Mol Med 2020
44
8

Melatonin Cytotoxicity Is Associated to Warburg Effect Inhibition in Ewing Sarcoma Cells.
Ana M Sanchez-Sanchez, Isaac Antolin, Noelia Puente-Moncada, Santos Suarez, Marina Gomez-Lobo, Carmen Rodriguez, Vanesa Martin. PLoS One 2015
35
8

Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
8

Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers.
Eleonora Rofi, Marzia Del Re, Elena Arrigoni, Mimma Rizzo, Lorenzo Fontanelli, Stefania Crucitta, Giulia Gianfilippo, Giuliana Restante, Stefano Fogli, Camillo Porta,[...]. Crit Rev Oncol Hematol 2019
5
40

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
Hans von der Maase, Lisa Sengelov, James T Roberts, Sergio Ricci, Luigi Dogliotti, T Oliver, Malcolm J Moore, Annamaria Zimmermann, Michael Arning. J Clin Oncol 2005
8


Inferring tumour purity and stromal and immune cell admixture from expression data.
Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, Rahulsimham Vegesna, Hoon Kim, Wandaliz Torres-Garcia, Victor Treviño, Hui Shen, Peter W Laird, Douglas A Levine,[...]. Nat Commun 2013
8

The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy.
Richard D Paucek, David Baltimore, Guideng Li. Trends Immunol 2019
25
8

Tumor microenvironment and therapeutic response.
Ting Wu, Yun Dai. Cancer Lett 2017
401
8

Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.
Nicole E Scharping, Ashley V Menk, Ryan D Whetstone, Xue Zeng, Greg M Delgoffe. Cancer Immunol Res 2017
189
8

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
Jong-Ho Cha, Wen-Hao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan, Seung-Oe Lim, Chia-Wei Li, Taewan Kim, Shih-Shin Chang, Heng-Huan Lee,[...]. Mol Cell 2018
199
8

Innate and adaptive immune cells in the tumor microenvironment.
Thomas F Gajewski, Hans Schreiber, Yang-Xin Fu. Nat Immunol 2013
8


Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
Eugene J Pietzak, Aditya Bagrodia, Eugene K Cha, Esther N Drill, Gopa Iyer, Sumit Isharwal, Irina Ostrovnaya, Priscilla Baez, Qiang Li, Michael F Berger,[...]. Eur Urol 2017
142
8

Emerging Immunotherapy Options for bacillus Calmette-Guérin Unresponsive Nonmuscle Invasive Bladder Cancer.
Maxwell V Meng, Jürgen E Gschwend, Neal Shore, Gary D Grossfeld, Hugh Mostafid, Peter C Black. J Urol 2019
10
20

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.
Carolyn D Hurst, Olivia Alder, Fiona M Platt, Alastair Droop, Lucy F Stead, Julie E Burns, George J Burghel, Sunjay Jain, Leszek J Klimczak, Helen Lindsay,[...]. Cancer Cell 2017
108
8

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.
Judith A Seidel, Atsushi Otsuka, Kenji Kabashima. Front Oncol 2018
389
8

Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Jonathan M Pitt, Marie Vétizou, Romain Daillère, María Paula Roberti, Takahiro Yamazaki, Bertrand Routy, Patricia Lepage, Ivo Gomperts Boneca, Mathias Chamaillard, Guido Kroemer,[...]. Immunity 2016
447
8

Therapeutic value of melatonin post-treatment on CCl4-induced fibrotic rat liver.
Keywan Mortezaee, Fatemeh Sabbaghziarani, Ameneh Omidi, Ahmad Reza Dehpour, Negar Omidi, Soudabeh Ghasemi, Parichehr Pasbakhsh, Iraj Ragerdi Kashani. Can J Physiol Pharmacol 2016
20
10

Targeting Free Radicals in Oxidative Stress-Related Human Diseases.
Patrik Poprac, Klaudia Jomova, Miriama Simunkova, Vojtech Kollar, Christopher J Rhodes, Marian Valko. Trends Pharmacol Sci 2017
315
8

Stromal reprogramming: A target for tumor therapy.
Masoud Najafi, Keywan Mortezaee, Jamal Majidpoor. Life Sci 2019
29
8

Oxidative stress and cancer: an overview.
Venus Sosa, Teresa Moliné, Rosa Somoza, Rosanna Paciucci, Hiroshi Kondoh, Matilde E LLeonart. Ageing Res Rev 2013
593
8


Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity.
Lianjun Zhang, Pedro Romero. Trends Mol Med 2018
83
8

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Surendra K Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V Chaika, Enza Vernucci, Ryan J King, Jaime Abrego, Gennifer D Goode, Aneesha Dasgupta,[...]. Cancer Cell 2017
175
8

Disruption of the redox balance with either oxidative or anti-oxidative overloading as a promising target for cancer therapy.
Bagher Farhood, Masoud Najafi, Eniseh Salehi, Nasser Hashemi Goradel, Maryam Shabani Nashtaei, Neda Khanlarkhani, Keywan Mortezaee. J Cell Biochem 2019
18
11

NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy.
Keywan Mortezaee, Nasser Hashemi Goradel, Peyman Amini, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, Masoud Najafi, Bagher Farhood. Curr Mol Pharmacol 2019
28
8

Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization.
Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed E Musa, Masoud Najafi, Bagher Farhood. Curr Clin Pharmacol 2019
24
8

Metabolic rearrangements in primary liver cancers: cause and consequences.
Letizia Satriano, Monika Lewinska, Pedro M Rodrigues, Jesus M Banales, Jesper B Andersen. Nat Rev Gastroenterol Hepatol 2019
32
8

Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer.
Miguel Reina-Campos, Juan F Linares, Angeles Duran, Thekla Cordes, Antoine L'Hermitte, Mehmet G Badur, Munveer S Bhangoo, Phataraporn K Thorson, Alicia Richards, Tarmo Rooslid,[...]. Cancer Cell 2019
64
8

Tumors as organs: complex tissues that interface with the entire organism.
Mikala Egeblad, Elizabeth S Nakasone, Zena Werb. Dev Cell 2010
684
8

T Cell Metabolism in a State of Flux.
Siva Karthik Varanasi, Shixin Ma, Susan M Kaech. Immunity 2019
2
100


Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Jun Fang, Takahiro Seki, Hiroshi Maeda. Adv Drug Deliv Rev 2009
315
8


Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Christopher J Halbrook, Costas A Lyssiotis. Cancer Cell 2017
146
8

Genetics and biology of pancreatic ductal adenocarcinoma.
Haoqiang Ying, Prasenjit Dey, Wantong Yao, Alec C Kimmelman, Giulio F Draetta, Anirban Maitra, Ronald A DePinho. Genes Dev 2016
242
8


Modulation of oxidative stress as an anticancer strategy.
Chiara Gorrini, Isaac S Harris, Tak W Mak. Nat Rev Drug Discov 2013
8

Cancer-associated fibroblasts: Secretions, interactions, and therapy.
Bagher Farhood, Masoud Najafi, Keywan Mortezaee. J Cell Biochem 2019
35
8

Connecting the Metabolic and Immune Responses to Cancer.
Thomas R Flint, Douglas T Fearon, Tobias Janowitz. Trends Mol Med 2017
35
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.